Celldex Therapeutics, Inc vs. Insight Molecular Diagnostics Inc. Common Stock
CLDX
Celldex Therapeutics, Inc
$31.65 -1.65%
VS IMDXInsight Molecular Diagnostics Inc. Common Stock
$3.44 -0.86%
Celldex Therapeutics, Inc and Insight Molecular Diagnostics Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| CLDX | IMDX | |
|---|---|---|
| Market Cap | $2.49 billion | $113.55 million |
| Revenue (TTM) | $158,000 | — |
| Net Income (TTM) | $-300,549,000 | — |
CLDX leads on 1 of 1 size & scale factors.
Valuation
| CLDX | IMDX | |
|---|---|---|
| Price / Book | 3.48 | — |
| Price / Sales | 15730.76 | — |
CLDX and IMDX split the valuation factors evenly.
Profitability
| CLDX | IMDX | |
|---|---|---|
| Net Margin | -190220.89% | — |
| Return on Equity | -42.06% | — |
CLDX and IMDX split the profitability factors evenly.
Risk & Sentiment
| CLDX | IMDX | |
|---|---|---|
| Short Interest | 9.28% | 0.93% |
IMDX leads on 1 of 1 risk & sentiment factors.
Dig deeper: CLDX overview, CLDX financials, IMDX overview, IMDX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.